Cumberland Pharmaceuticals (CPIX) Invested Capital (2010 - 2024)

Cumberland Pharmaceuticals (CPIX) posted Invested Capital of $5.1 million for Q4 2024, down 14.84% sequentially from $6.0 million in Q3 2024.

Cumberland Pharmaceuticals (CPIX) Invested Capital (2010 - 2024) Analysis & Trends

Cumberland Pharmaceuticals has reported Invested Capital for 4 years, with the latest figure at $5.1 million in Q4 2024.

Quarterly Invested Capital changed N/A year-over-year to $5.1 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $5.1 million (down 14.84% YoY) and the FY2024 annual result came in at $5.1 million, changed N/A from the prior year.
Invested Capital declined to $5.1 million in Q4 2024 per CPIX's latest filing, from $6.0 million in the prior quarter.
Over five years, Invested Capital peaked at $6.0 million in Q3 2024 and troughed at $2.0 million in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	4.50 Bn
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	630.00 Mn
10	Cumberland Pharmaceuticals	116.56 Mn	112.69 Mn	-	-

Download Data